SCHEMBL22011802

SCHEMBL22011802

CCCCCc1ccc(-c2cc3oc4cc(OCC)c(F)c(F)c4c3c(F)c2F)c(F)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 1/20 0.38
CTSS P25774 1/20 0.38
CTSK P43235 1/20 0.38
KDM4E B2RXH2 8/20 0.34
NOD2 Q9HC29 1/20 0.34
MEN1 O00255 10/20 0.33
KMT2A Q03164 10/20 0.33
HTT P42858 7/20 0.33
ALDH1A1 P00352 7/20 0.33
MAPT P10636 6/20 0.33
GAA P10253 5/20 0.33
POLB P06746 4/20 0.33
NPSR1 Q6W5P4 3/20 0.33
HPGD P15428 3/20 0.33
APAF1 O14727 3/20 0.33
USP2 O75604 3/20 0.33
ATM Q13315 2/20 0.33
GLA P06280 2/20 0.33
TSHR P16473 2/20 0.33
BLM P54132 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22010811 0.87 KDM4E (0.36) KDM4ENOD2MEN1KMT2AHTT
SCHEMBL22011104 0.85 NAAA (0.33) MEN1KMT2AHTTALDH1A1MAPT
SCHEMBL22011234 0.85 CTSL (0.38) CTSLCTSSCTSKKDM4EMEN1
SCHEMBL22011189 0.84 RARB (0.37) MAPTGPR55
SCHEMBL22010964 0.83 KDM4E (0.37) KDM4ENOD2MEN1KMT2AHTT
SCHEMBL22010796 0.82 L3MBTL1 (0.35) ALDH1A1MAPTGAANPSR1THRB
SCHEMBL22010955 0.81 RARB (0.40) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL22011810 0.80 ATM (0.32) KDM4EALDH1A1MAPTGAAATM
SCHEMBL22010968 0.79 PGAM1 (0.42)
SCHEMBL22011226 0.78 HMGCR (0.36) CTSLCTSSCTSKKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device YBX1, ZKSCAN2, RCC1 CTSL 3548/4885CTSS 2594/4885CTSK 3102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.